HMOX1 and neoplasm: Delayed the progression of breast cancer and melanoma by increasing the number of bone marrow common lymphoid progenitor cells and cytotoxic CD8+ tumor-infiltrating lymphocytes and, at least in a mouse breast cancer model, the downregulation of the stress-responsive enzyme heme oxygenase-1